• Title/Summary/Keyword: infusion rate

검색결과 351건 처리시간 0.026초

The evaluation of implementing smart patient controlled analgesic pump with a different infusion rate for different time duration on postoperative pain management

  • Kim, Saeyoung;Jeon, Younghoon;Lee, Hyeonjun;Lim, Jung A;Park, Sungsik;Kim, Si Oh
    • Journal of Dental Anesthesia and Pain Medicine
    • /
    • 제16권4호
    • /
    • pp.289-294
    • /
    • 2016
  • Background: Control of postoperative pain is an important aspect of postoperative patient management. Among the methods of postoperative pain control, patient-controlled analgesia (PCA) has been the most commonly used. This study tested the convenience and safety of a PCA method in which the dose adjusted according to time. Methods: This study included 100 patients who had previously undergone orthognathic surgery, discectomy, or total hip arthroplasty, and wished to control their postoperative pain through PCA. In the test group (n = 50), the rate of infusion was changed over time, while in the control group (n = 50), drugs were administered at a fixed rate. Patients' pain scores on the visual analogue scale, number of rescue analgesic infusions, side effects, and patients' satisfaction with analgesia were compared between the two groups. Results: The patients and controls were matched for age, gender, height, weight, and body mass index. No significant difference in the mount of drug administered was found between the test and control groups at 0-24 h after the operation; however, a significant difference was observed at 24-48 h after the operation between the two groups. No difference was found in the postoperative pain score, number of side effects, and patient satisfaction between the two groups. Conclusions: Patient-controlled anesthesia administered at changing rates of infusion has similar numbers of side effects as infusion performed at a fixed rate; however, the former allows for efficient and safe management of postoperative pain even in small doses.

The Role of Brain Somatostatin in the Central Regulation of Feed, Water and Salt Intake in Sheep

  • Sunagawa, Katsunori;Weisinger, Richard S.;McKinley, Michael J.;Purcell, Brett S.;Thomson, Craig;Burns, Peta L.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제14권7호
    • /
    • pp.929-934
    • /
    • 2001
  • The physiological role of brain somatostatin in the central regulation of feed intake in sheep was investigated through a continuous intracerebroventricular (ICV) infusion of somatostastin 1-28 (SRIF) at a small dose of $5{\mu}g/0.2ml/hr$ for 98.5 hours from day 1 to day 5. Sheep (n=5) were fed for 2 hours once a day, and water and 0.5 M NaCI solution were given ad libitum. Feed, water and salt intake were measured during ICV infusion of artificial cerebrospinal fluid (CSF) and SRIF. The feed intake during SRIF infusion on days 2 to 5 increased significantly compared to that during CSF infusion. Water intake, when compared to that during CSF infusion, only increased significantly on day 4. NaCI intake during SRIF infusion was not different from that during CSF infusion. Mean arterial blood pressure (MAP) and heart rate during SRIF infusion were not different from those during CSF infusion. The plasma concentrations of Na, K, Cl, osmolality and total protein during SRIF infusion were also not different from those values during CSF infusion.There are two possible mechanisms, that is, the suppression of brain SRIF on feed suppressing hormones and the direct actions on brain mechanisms controlling feed intake, explaining how SRIF works in the brain to bring about increases in feed intake in sheep fed on hay. The results indicate that brain SRIF increases feed intake in sheep fed on hay.

The Role of Corticotropin-Releasing Factor and Urocortin in Brain Mechanisms Controlling Feed Intake of Sheep

  • Sunagawa, K.;Weisiger, R.S.;McKinley, M.J.;Purcell, B.S.;Thomson, C.;Burns, P.L.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제13권11호
    • /
    • pp.1529-1535
    • /
    • 2000
  • The aim of the present study was to determine whether brain corticotropin-releasing factor (CRF) and a new peptide, urocortin (UCN) have a direct action in brain mechanisms controlling feed, water and salt intake in sheep. We gave a continuous intracerebroventricular (ICV) infusion of the peptide at a small dose of $5{\mu}g/0.2ml/hr$ for 98.5 hrs from day 1 to day 5 in sheep not exposed to stress. Feed and water intake during ICV infusion of CRF or UCN decreased significantly compared to those during artificial cerebrospinal fluid (CSF) infusion. NaCl intake during infusion of CRF or UCN was the same as that during CSF infusion. Mean carotid arterial blood pressure (MAP) and heart rate during ICV infusion of CRF or UCN were not significantly different from that during CSF infusion. On the other hand, the plasma glucose concentration during ICV infusion of CRF or UCN tended to be higher than that during CSF infusion. These observations indicate that decreased feed intake induced by CRF and UCN infusion is not mediated by the activation of both the pituitary-adrenal axis and the sympathetic nervous system. The results suggested that brain CRF and UCN act directly in brain mechanisms controlling ingestive behavior to decrease feed and water intake, but do not alter salt intake in sheep.

Evaluations of vital signs and echocardiographic left ventricular function after the constant rate infusion of lidocaine and/or ketamine in Beagle dogs

  • Kim, Ye-Won;Choi, Miru;Kim, Tae-Jun;Hyun, Changbaig
    • 대한수의학회지
    • /
    • 제55권4호
    • /
    • pp.215-219
    • /
    • 2015
  • Cardiopulmonary depression of long-term constant rate infusion (CRI) administration of multiple analgesic drugs is important, especially in critically ill dogs. Therefore, this study was conducted to evaluate the effects of lidocaine, ketamine or combined lidocaine-ketamine combination CRI treatment on vital signs and left ventricular (LV) function in healthy dogs. Six adult Beagle dogs were administered either ketamine (initial loading dose of 0.5 mg/kg followed by $10{\mu}g/kg/min$ CRI), lidocaine (initial loading dose of 2 mg/kg followed by 0.025 mg/kg/min CRI), or combined lidocaine-ketamine intravenously. Arterial blood pressure (BP), heart rate (HR), respiratory rate (RR), body temperature (BT) and echocardiographic LV dimensions were measured before administration of medications, immediately after administration of drugs, and then every 10 min for 2 h. There were no significant changes in HR, RR, BT and BP after the administration of either lidocaine CRI, ketamine CRI, or combined lidocaine and ketamine CRI. There were also no significant changes in LV dimensions and stroke volume. The results revealed that treatment with either lidocaine, ketamine or combined lidocaine-ketamine may not cause cardiopulmonary suppression in healthy dogs.

개에서 주사 및 도입마취제로서 Propofol의 마취효과 및 심폐기능에 미치는 영향 (Anesthetic and Cardiopulmonary Effects of Propofol as Infusion and Induction Anesthesia in Dogs)

  • 유준호;이충호;김완희;남치주;권오경
    • 대한수의학회지
    • /
    • 제42권1호
    • /
    • pp.123-130
    • /
    • 2002
  • To investigate the cardiopulmonary and anesthetic effects of propofol in dogs, experimental dogs were randomly divided into 4 groups (propofol infusion anesthesia, P/INF, propofol intermittent anesthesia, P/INTER, propofol induction anesthesia, P/ISO, thiopental Na induction anesthesia, T/ISO) and monitored analgesic and anesthetic effects, recovery time, body temperature, heart rate, mean arterial pressure, respiratory rate, systolic and diastolic pressure. In all groups, apnea was not observed. In the P/INF group, the respiratory rate(RR) was slightly decreased, but in the P/INTER group, RR was increased and shallowing. In the groups of P/ISO and T/ISO, the respiratory rate was decreased. Heart rate(HR) was increased after induction anesthesia in all groups, but gradually decreased. Mean arterial pressure(MAP) was decreased after injection anesthesia in the groups of P/INF and P/INTER. In the groups of P/ISO and T/ISO, however, MAP was slightly increased. Systolic and diastolic arterial pressure were gradually decreased after induction anesthesia, but not significantly. In the groups of P/INF and P/ISO, recovery time was shorter than the groups of P/INTER and T/ISO. In all groups, body temperature of animals was decreased gradually according to time but no significant changes were observed. Propofol injection doesn't make the complete loss of responses of animals, especially, in the P/INTER group. In the P/INF group, deep pain was present until the end of anesthetic period. During recovery period, any other side effects except incoordination were not monitored. The present study suggested that infusion anesthesia was superior to intermittent anesthesia as injection anesthetic agent, and propofol was better than thiopental Na as induction anesthetic agent.

Continuous-infusion Ifosfamide and Doxorubicin Combination as Second-Line Chemotherapy for Recurrent or Refractory Osteosarcoma Patients in China: a Retrospective Study

  • Huang, Yu-Jing;He, Ai-Na;Sun, Yuan-Jue;Shen, Zan;Min, Da-Liu;Yao, Yang
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권6호
    • /
    • pp.2391-2395
    • /
    • 2015
  • Objective: The aim of this retrospective study was to evaluate the feasibility and efficacy of response to continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for patients with recurrent or refractory osteosarcoma. Materials and Methods: Eighteen recurrent or refractory osteosarcoma patients who were treated with continuous-infusion ifosfamide and doxorubicin combination between May 1999 and April 2011 were included in the analysis. Ifosfamide at $12g/m^2$ was administered by intravenous continuous infusion over 3 days, and doxorubicin $60mg/m^2$ was administered as an intravenous bolus injection on day 1. The combination therapy was repeated every 3 weeks. Treatment was continued until evidence of disease progression or unacceptable toxicity. Results: The patients (ages 7-53 years) received a total of 42 cycles of chemotherapy (median: 2 courses; range: 2-5 courses). The overall response rate was 0% and the disease control rate was 22.3%, with four patients having stable disease. The median time to progression and overall survival time were 2 months (range: 2-5 months) and 9 months (range: 3-29 months), respectively. Major severe toxicities were leucopenia 7 (38.9%), nausea and vomiting 3 (16.7%) and alopecia 9 (50%). There were no treatment-related deaths. Conclusions: In our experience, continuous-infusion ifosfamide and doxorubicin combination therapy at this dosage and schedule was found to be well tolerated and moderate effective, which could be considered as salvage therapy for patients with recurrent or refractory osteosarcoma. Further assessment is necessary to confirm the safety and efficacy of this treatment.

고무 치공구와 필름 함침공정을 이용한 열가소성 장섬유 복합재료 성형공정 연구 (Thermoplastic Film Infusion Process for Long Fiber Reinforced Composites Using Rubber Expandable Tools)

  • 김동욱;안영선;이영관;김성우;남재도
    • 폴리머
    • /
    • 제25권1호
    • /
    • pp.122-132
    • /
    • 2001
  • 본 연구에서는 온도의 상승에 의하여 팽창하는 열팽창 기능을 가지고 있으면서 부피의 감소에 의하여 발생하는 압력의 손실을 상쇄시킬 수 있는 고무 치공구를 열가소성 고분자의 필름 함침공정에 적용하였다. 일반적인 압축성형공정에서는 온도의 상승에 의하여 수지가 용융되고 이에 수지가 함침됨에 따라 압력이 감소하지만, 고무 치공구를 사용한 경우에는 수지의 함침을 보상한 고무 치공구가 팽창하여 감소된 압력을 보상하기 때문에 급격한 압력의 강하를 억제할 수 있었다. 이렇게 수지의 함침에 따른 고무 치공구의 부피 팽창 그리고 이에 따른 수지 함침속도의 변화를 고려하여 고무 치공구를 이용한 필름 함침공정 모델을 제안하였다. 또한 고무 치공구를 사용하지 않는 일반적인 압축공정에 있어서 수지의 함침에 따른 섬유층 탄성력의 변화를 실험적으로 측정하여 단계적인 압축공정에 있어서 수지의 함침속도를 예측할 수 있는 모델을 제안하였다.

  • PDF

탄성 블리스터 액츄에이터를 이용한 일회용 미세유체 주입펌프 (Disposable Microfluidic Infusion Pump using Elastomeric Blister Actuator)

  • 장웅기;김형진;김병희;서영호
    • 한국생산제조학회지
    • /
    • 제22권2호
    • /
    • pp.235-240
    • /
    • 2013
  • This paper presents a disposable microfluidic infusion pump using the restoring force of elastomeric membrane of Polydimethylsiloxane. Microfluidic infusion pump consists of hydraulic resistance control part, elastomeric blister actuator part, drug inlet and outlet. Expanded elastomeric blister actuator continuously pushes liquid in the chamber to outlet. At same time, microchannel diameter near the outlet was controlled by thin elastomeric membrane in hydraulic resistance control part. Eventually flow rate of infused liquid is controlled by air pressure. In experimental study, the amount of the filled liquid in the blister is precisely controlled by the height of the blister. Flow rate of infused liquid could be controlled, that is, controlled release of the drug over time was possible by adjusting hydraulic resistance and restoring pressure with the blister actuator.

카테콜아민계 승압제를 투여중인 패혈성 쇼크 환자에서 아르기닌 바소프레신(AVP)의 효과 (Effects of Arginine Vasopressin(AVP) Infusion on the Patients with Catecholamine-dependent Septic Shock)

  • 신승수;임승관;조숙경;송경은;이형노;오윤정;박광주;황성철
    • Tuberculosis and Respiratory Diseases
    • /
    • 제55권5호
    • /
    • pp.506-515
    • /
    • 2003
  • 연구배경 : 패혈성 쇼크에서는 혈압이 저하됨에도 불구하고 혈중 AVP의 농도가 낮은데, 그 이유는 미생물에서 유리된 독소에 따른 염증반응을 매개로 증가한 산화질소(NO)가 혈관을 확장시켜 이차적으로 AVP의 고갈을 유발하기 때문인 것으로 알려져 있다. 한편 패혈성 쇼크의 치료를 위해 사용하는 노르에피네프린과 카테콜아민계 승압제는 다량 사용시 내부 장기의 혈류감소를 유발할 수 있다. 이에 본 저자들은 페혈성 쇼크 환자에게 AVP를 정주함으로써 승압제의 감량과 신기능의 향상이 일어나는지 알아보았다. 방 법 : 혈압의 유지를 위해 다량의 승압제를 투여중인 여덟 명의 패혈성 쇼크 환자들을 대상으로 AVP를 4시간 동안 정주하였다. 투여전, 투여중 및 투여 종료 4시간 경과후 시점을 기준으로 평균 동맥압 및 노르에피네프린의 투여속도, 시간당 소변량을 측정하였다. 결 과 : AVP의 정주 결과, 세 측정 시점 사이에서 평균 동맥압의 유의한 변화는 일어나지 않은 채로(p=0.197) 노르에피네프린의 투여속도(${\mu}g/min$)을 유의하게 감소시킬 수 있었다(p=0.001). 그러나, 시간당 소변량은 측정 시점 사이에 차이가 없었다(p=0.093). 결 론 : 패혈성 쇼크 환자에게 AVP를 정주한 결과, 카테콜아민계 승압제의 투여속도를 유의하게 줄일 수 있었다. 그러나 단시간 AVP 정주에 따른 시간당 소변량은 유의한 변화를 나타내지 않아 향후 AVP 투여가 주요 장기 및 생존율에 미치는 영향에 대한 추가 연구가 필요할 것이다.

아동의 말초정맥주사 간호프로토콜 적용 및 효과 (The Application and Effect of the Nursing Protocol of Pediatric Peripheral Intravenous Infusion)

  • 최희강;강미정;강현주;김은혜
    • Perspectives in Nursing Science
    • /
    • 제14권2호
    • /
    • pp.45-54
    • /
    • 2017
  • Purpose: The aim of this study was to compare the effect of training and implementation of a pediatric peripheral intravenous infusion protocol on the nurses' performance and infusion complication rate. Methods: A quasiexperimental study using a posttest comparison of a one group pretest-time series design was utilized. This method was developed to measure nursing knowledge and performance based on a pediatric peripheral intravenous infusion protocol. To calculate the occurrence rate of complications, the number of complications were divided into the number of intravenous insertions. Results: It was shown that the training developed by the study team in 2015 contributed to nurses' increased knowledge, as well as improved job performance. Furthermore, the implementation of the protocol revealed that the number of peripheral intravenous insertions, an invasive procedure, decreased. Additionally, the nursing workload related to pediatric intravenous infusions was reduced. Conclusion: This protocol may contribute to the improved scientific quality and efficiency of nursing management of peripheral intravenous infusions.